Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1996-02-05
1999-11-09
Eisenschenk, F C
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 855, 424 856, 424 857, 530351, A61K 3821, A61K 3819, C07K 14555, C07K 1456
Patent
active
059808845
ABSTRACT:
Methods for the retreatment, using a therapeutically effective amount of interferon consensus, of patients with HCV who exhibit serum ALT values above the upper limit of normal after previous treatment with interferon.
REFERENCES:
patent: 4695623 (1987-09-01), Stabinsky
patent: 4897471 (1990-01-01), Stabinsky
patent: 5372808 (1994-12-01), Blatt et al.
Arase et al., "Interferon Retreatment of Nonresponders with HCV-RNA-Positive Chronic Hepatitis C", J. Gastroenterol., 29: 299-304 (1994).
Marcellin et al., "Retreatment with Recombinant Interferon-alpha in Patients with Chronic Hepatitis C", Journal of Infectious Diseases, 167:780-781 (1993).
Marriott et al., "Retreatment of Chronic Hepatitis C with Interferon-alpha", Journal of Infectious Diseases, 166:1200-1201 (1992).
Schvarcz et al, "Interferon alpha-2b Treatment of Chronic Posttransfusion non-A, non-B/C Hepatitis: Long term Outcome and Effect of Increased Interferon Doses in Non-Responders", Scand J. Infect Dis, 23: 413-420 (1991).
Toyoda et al, "Retreatement of Chronic Hepatitis C with Interferon", American Journal of Gastroenterology, 89(9): 1453-1457 (1994).
Welland et al, "Serum HCV RNA Levels in Patients with Chronic Hepatitis C Given a Second Course of Interferon alpha-2b Treatment after Relapse Following Initial Treatment", Scand J. Infect Dis, 25:25-30 (1993).
Iino et al. Intervirology 37:87-100, 1994.
Tong et al (A) Gastroenterology 108 (4 Suppl.):A1188, 1995 top right.
Marcellin et al. (AB) J. Infectious Dis. 167:780-781, 1993.
Bresci et al. J. Viral Hepatitis v2, N3:155-158, 1995.
Ozes et al. J. Interferon Res. 12:55-59, 1992.
Tong et al. (B) Gastroenterology 108 (4 Suppl.):A1188, top left Abstract, 1995.
Tong et al. (C) Hepatology 18 (part 4):150A, abstract No. 376, 1993.
M.J. Tong et al., "Retreatment of Patients with Chronic Hepatitis C Virus Infection with Consensus Interferon Results of a Maintenance Study", Gastroenterology, vol. 108, No. 4, Suppl., Apr. 1995, New York, N.Y., U.S.
M.J. Tong, et al., "Long-Term Follow-Up of Patients Treated with Consensus Interferon", Gastroenterology, vol. 108, No. 4 Suppl., Apr. 1995, New York, N.Y., U.S.
M.J. Tong, et al., "Treatment of Patients with Chronic HCV Infection with a Novel Type-1 Interferon, Consensus Interferon", Hepatology, vol. 18, No. 4 Part 2, Oct. 1993, Baltimore, PA, U.S.
D.M. Jensen, et al., "Treatment of High Viral Titer Chronic HCV Patients with Consensus Interferon (CIFN) Results in a Significantly Greater Number of Sustained HCV RNA Reponsders as Compared to Treatment with Interferon Alpha-2b", Hepatology, vol. 24, No. 4 Part 2, Oct. 1996, Baltimore, PA, U.S.
Infergen (Interferon alfacon-1); (Oct. 1997).
Alberti, et al. "Therapy of Hepatitis C: Re-Treatment with Alpha Interferon"; Hepatology vol. 26, No. 3 (Sep. 1997) pp. 137-142.
Heathcote, et al. "Re-treatment of Chronic Hepatitis C with Consensus Interferon"; Hepatology (Apr. 1998) pp. 1136-1143.
Blatt Larry
Klein Michael
Amgen Inc.
Crandall Craig A.
Eisenschenk F C
Levy Ron K.
Odre Steven M.
LandOfFree
Methods for retreatment of patients afflicted with Hepatitis C u does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for retreatment of patients afflicted with Hepatitis C u, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for retreatment of patients afflicted with Hepatitis C u will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1451767